Trump recently announced plans to impose a 200 per cent tariff on pharmaceuticals and a 50 per cent levy on copper imports, with pharmaceutical companies given a transition period to relocate production to the US. Chalmers emphasised that while Australia’s copper exports to the US are minimal, the impact on pharmaceuticals could be severe.
The US has previously criticised Australia’s Pharmaceutical Benefits Scheme (PBS), which subsidises over 900 medicines, as anti-competitive. Chalmers reaffirmed the government’s commitment to protecting the PBS, stating, “We will not trade away or do deals on the PBS in trade negotiations.”
Hence then, the article about australia deeply concerned over us pharmaceutical tariff threats was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Australia deeply concerned over US pharmaceutical tariff threats )
Also on site :